Authors



Donald Levick, MD, MBA

Latest:

Improving Medication Guidance Needs to be a Top Priority for Hospitals, Health Systems

More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.



Allyson Gill, PharmD Candidate

Latest:

Case Study: Pharmacist Management of Inappropriate Prednisone Dosing Triggered By Asthma

Holistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.


Elise Carpenter, PharmD, BCACP

Latest:

Ambulatory Care Pharmacist-Administered Depression Screenings Can Close Gaps in Care

The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.


Amin Khudari, PharmD Candidate

Latest:

USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ Disease

Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.


Martina Nasralla, PharmD Candidate

Latest:

A Pharmacist’s Guide to Lung Cancer and Its Key Treatments

Though new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.


Steve Martinson

Latest:

The Tao of Tau: Developing the “My Vancomycin Calculator” App

Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.



Nick Crozier, PharmD, MBA, BCPS, BCOP

Latest:

Driving Clinical Pharmacy Development With Data-Driven Metrics and Insights

There are no clearly defined, widely accepted clinical pharmacist metrics.


Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Latest:

Innovations in Hematology and Oncology Explored at HOPA Annual Conference

Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, shared insight from the HOPA Annual Meeting 2025.


Christy Cheung, PharmD

Latest:

Artificial Intelligence Applications in Education and Pharmacy Practice

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.


Celeste Chung, PharmD

Latest:

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.


Steven Pipe, MD

Latest:

Expert: Pharmacists Play Key Role in Counseling, Managing Expectations for Etranacogene Dezaparvovec

Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.


Amit Patel, MD

Latest:

Pharmacy-Led Enhanced Patient Education in the Emergency Department

In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.


Rachel Chandra, PharmD, MPH, FASHP

Latest:

Understanding Gender-Affirmative Care Beyond Women’s Health

Gender-affirming care and inclusive practices are essential for health equity.


Hannah Ayers

Latest:

Case Studies: May 2022

How would you handle these patients' questions?


Gary Hopkins

Latest:

Medically Integrated Health System Specialty Pharmacies Deliver Strong Outcomes

These facilities provide significant value to payers and patients.


Jerry Rebo, PharmD, BCPS, BCCCP, DPLA

Latest:

Sugammadex: Use Criteria Optimization and Outcomes Data Evaluation

Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.


Enriqueta Felip, MD, PhD

Latest:

Subcutaneous Pembrolizumab Matches IV in Lung Cancer Trial

Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.



Zachery Halford, PharmD, BCOP, BCPPS

Latest:

Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial Carcinoma

This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.


Shashank R. Cingam, MD

Latest:

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.


Margaret T Peinovich, PharmD, BCPS

Latest:

Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion Clinic

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.


Ashley L. Weaver, PharmD Candidate

Latest:

Understand the Emergency Management Assistance Comp

This interstate agreement can empower pharmacists to respond to large-scale emergencies


Kaitlin Beyler, PharmD Candidate 2023

Latest:

For the First Time Ever, CDC Makes Specific Recommendations on Flu Vaccines for Geriatric Patients

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.


Rachel Massey, PharmD Candidate

Latest:

What You Should Know About Norgestrel, An OTC Birth Control Option

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.


Robin R. Vidal, PharmD

Latest:

The Role of Pharmacists and Prescription Monitoring Programs in Stemming the Opioid Epidemic

Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.


Tiffany Capps, CPhT

Latest:

Career Pathways Play Key Part in Retention

Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.


Michele Riccardi, PharmD, BCPS

Latest:

Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer

Even when safe, oral supplement use may not be appropriate to use during cancer treatment or recovery.